Hyperparathyroidism, unspecified
ICD-10 E21.3 is a billable code used to indicate a diagnosis of hyperparathyroidism, unspecified.
Hyperparathyroidism is a condition characterized by an overproduction of parathyroid hormone (PTH) from the parathyroid glands, which are small glands located in the neck behind the thyroid. This condition can lead to elevated levels of calcium in the blood (hypercalcemia), which can cause a variety of symptoms including fatigue, weakness, depression, and bone pain. The parathyroid glands play a crucial role in regulating calcium levels in the body, and when they become overactive, it can disrupt the balance of calcium and phosphorus, leading to potential complications such as osteoporosis, kidney stones, and cardiovascular issues. Hyperparathyroidism can be classified into primary, secondary, and tertiary types, but when unspecified, it indicates that the exact cause or type has not been determined. This condition is often diagnosed through blood tests that measure calcium and PTH levels, and imaging studies may be used to assess for any underlying causes such as tumors or hyperplasia of the parathyroid glands. Treatment options may include surgical intervention, medication, or monitoring, depending on the severity and underlying cause of the hyperparathyroidism.
Detailed lab results, imaging studies, and treatment plans.
Patients presenting with symptoms of hypercalcemia, routine follow-ups for known hyperparathyroidism.
Endocrinologists must document the specific type of hyperparathyroidism when known, as this affects treatment and management.
Assessment of kidney function and calcium-phosphate balance.
Patients with chronic kidney disease presenting with secondary hyperparathyroidism.
Nephrologists should document the relationship between kidney function and parathyroid hormone levels.
Used to assess calcium levels in patients suspected of hyperparathyroidism.
Document the reason for the test and any relevant clinical findings.
Endocrinologists should ensure that calcium levels are monitored regularly.
Common symptoms include fatigue, weakness, depression, bone pain, and kidney stones. Patients may also experience gastrointestinal issues such as nausea and constipation.
